Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Sales/Fixed Asset

    Back to All Ratios
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 1.421.571.261.020.93

What is the latest Sales/Fixed Asset ratio of BAFNA PHARMACEUTICALS ?

The latest Sales/Fixed Asset ratio of BAFNA PHARMACEUTICALS is 1.42 based on Mar2025 Standalone results.
Year Sales/Fixed Asset
Mar20251.42
Mar20241.57
Mar20231.26
Mar20221.02
Mar20210.93

How is Sales/Fixed Asset of BAFNA PHARMACEUTICALS Trending?

Years Sales/Fixed Asset % Change
Mar2025 1.42
-9.55
Mar2024 1.57
24.60
Mar2023 1.26
23.53
Mar2022 1.02
9.68
Mar2021 0.93 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Sales/Fixed Asset ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹268.9 Cr -9.3% 3.3% 49.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-9.3%

3.3%

49.4%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses